Abstract
Since anticoagulants of the coumarin type have been reported to decrease at least four coagulation factors, there is doubt as to which test to use in the control of anticoagulant therapy. Early extensive experience showed the Quick prothrombin time alone to suffice for laboratory control of therapy with coumarin-type anticoagulants. Subsequent failures with this test are explained by the use of unsatisfactory thromboplastin.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
